(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Adaptimmune Therapeutics is 3188020
Date | Daily Closing Price | Open | High | Low | Volume |
20 Wed Nov 2024 | 0.66 | 0.68 | 0.71 | 0.64 | 1.305 times |
19 Tue Nov 2024 | 0.67 | 0.60 | 0.68 | 0.57 | 1.71 times |
18 Mon Nov 2024 | 0.60 | 0.60 | 0.64 | 0.58 | 0.563 times |
15 Fri Nov 2024 | 0.59 | 0.59 | 0.61 | 0.58 | 1.627 times |
14 Thu Nov 2024 | 0.59 | 0.81 | 0.81 | 0.58 | 4.554 times |
13 Wed Nov 2024 | 0.77 | 0.82 | 0.83 | 0.75 | 0.487 times |
12 Tue Nov 2024 | 0.79 | 0.82 | 0.82 | 0.76 | 0.178 times |
11 Mon Nov 2024 | 0.82 | 0.81 | 0.83 | 0.78 | 0.232 times |
08 Fri Nov 2024 | 0.80 | 0.78 | 0.80 | 0.75 | 0.216 times |
07 Thu Nov 2024 | 0.78 | 0.82 | 0.83 | 0.77 | 0.228 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 0.7, but if it comes above 0.7, then a intra day buy could be more profitable.
If you take a sell trade below 0.7, then use 0.7 as stoploss and 0.6 as target. However if you take a buy trade in stock , then use 0.7 as stoploss and 0.74 as target.
Share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Target | 0.57 |
Upside Target | 0.67 |
Upside Target | 0.71 |
Upside Target | 0.75 |
Upside Target | 0.82 |
Upside Target | 0.85 |
Upside Target | 0.87 |
Upside Target | 0.94 |
Upside Target | 0.96 |
Upside Target | 0.98 |
Upside Target | 1.32 |
Upside Target | 1.36 |
Upside Target | 1.48 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Intraday Target | 0.58 |
Downside Intraday Target | 0.51 |
Upside Intraday Target | 0.72 |
Upside Intraday Target | 0.79 |
Downside Intraday Target | 0.65 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Weekly Closing Price | Open | High | Low | Volume |
20 Wed Nov 2024 | 0.66 | 0.60 | 0.71 | 0.57 | 0.505 times |
15 Fri Nov 2024 | 0.59 | 0.81 | 0.83 | 0.58 | 6.021 times |
08 Fri Nov 2024 | 0.80 | 0.80 | 0.86 | 0.75 | 0.512 times |
01 Fri Nov 2024 | 0.80 | 0.74 | 0.82 | 0.67 | 1.256 times |
25 Fri Oct 2024 | 0.74 | 0.84 | 0.85 | 0.72 | 0.919 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Monthly Closing Price | Open | High | Low | Volume |
20 Wed Nov 2024 | 0.66 | 0.73 | 0.86 | 0.57 | 1.451 times |
31 Thu Oct 2024 | 0.73 | 0.94 | 0.96 | 0.67 | 1.299 times |
30 Mon Sep 2024 | 0.95 | 1.24 | 1.32 | 0.87 | 0.403 times |
30 Fri Aug 2024 | 1.27 | 1.33 | 1.36 | 0.94 | 1.214 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Adaptimmune Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Adaptimmune Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.63 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Adaptimmune Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Adaptimmune Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.63 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.